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Background: Malignant pleural effusion (MPE) is an extremely common problem affecting cancer patients, and
thoracentesis is an essential procedure in an attempt to delineate the etiology of the fluid collections and to relieve
symptoms in affected patients. One of the most common complications of thoracentesis is pneumothorax, which
has been reported to occur in 20% to 39% of thoracenteses, with 15% to 50% of patients with pneumothorax
requiring tube thoracostomy.
The present study was carried out to assess whether thoracenteses in cancer patients performed with ultrasound
(US) guidance are associated with a lower rates of pneumothorax and tube thoracostomy than those performed
without US guidance.
Methods: A total of 445 patients were recruited in this retrospective study. The medical records of 445 consecutive
patients with cancer and MPE evaluable for this study, undergoing thoracentesis at the Oncology-Hematology and
Internal Medicine Departments, Piacenza Hospital (Italy) were reviewed.
Results: From January 2005 to December 2011, in 310 patients (69.66%) thoracentesis was performed with
US guidance and in 135 (30.34%) without it. On post-thoracentesis imaging performed in all these cases, 15
pneumothoraces (3.37%) were found; three of them (20%) required tube thoracostomy. Pneumothorax occurred
in three out of 310 procedures (0.97%) performed with US guidance and in 12 of 135 procedures (8.89%)
performed without it (P <0.0001). It must be emphasized that in all three patients with pneumothorax requiring
tube thoracostomy, thoracentesis was performed without US guidance.
Conclusions: The routine use of US guidance during thoracentesis drastically reduces the rate of pneumothorax
and tube thoracostomy in oncological patients, thus improving safety as demonstrated in this study.
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Malignant pleural effusions (MPE) are an extremely com-
mon problem affecting cancer patients both at the onset
or during the course of the disease, and thoracentesis is a
commonly performed procedure whereby pleural fluid is
aspirated percutaneously through the chest wall for diag-
nostic or therapeutic purpose.
Potential complications of thoracentesis are pain (5%),
cough (24%), shortness of breath (15%), vasovagal reac-
tion (3%), and pneumothorax (20% to 39%) [1].
Less common complications of thoracentesis include
inadvertent liver or splenic puncture, bleeding, subcuta-
neous emphysema, re-expansion pulmonary edema, and
infection [1]. Iatrogenic pneumothorax resulting from
thoracentesis increases morbility, mortality, and length
of hospitalization. In addition, chest tube insertion may
be required in up to 50% of cases, with a mean duration
of placement of approximately 4 days [2,3]. Approxi-
mately 1.5 million people are found to have pleural effu-
sion each year in the United States [4], and although
thoracentesis is typically considered by physicians a rela-
tively safe procedure with few complications [4], the
incidence of pneumothorax has been reported to be as
high as 20% to 39% [5].
Factors that have been shown to reduce the rate of
pneumothorax include the performance by experienced
personnel [6], as well as the use of US guidance [5,7-9].
While the usefulness of US guidance in reducing the inci-
dence of pneumothorax from thoracentesis has been re-
ported in several studies [5,7-9] and in a recent meta
analysis [10], to our knowledge the incidence of pneumo-
thorax from US-guided or unguided bedside thoracentesis
in cancer patients is less well documented.
The purpose of this study was to assess the rate of
pneumothorax associated with US-guided or unguided
thoracentesis in clinical practice in cancer patients attend-
ing the oncological-hematological and internal medicine
departments of a North Italian general hospital, the
Piacenza Hospital.
Methods
After approval by the institutional review board (Ethic
Committee Azienda Sanitaria di Piacenza (Italy)), a search
was conducted in the medical records of cancer patients
to identify those patients with pleural effusion who under-
went thoracentesis.
A total of 462 consecutive patients with cancer who
underwent thoracentesis at the oncology-hematology
and internal medicine departments over a 6-year period
(2 January 2005 to 31 December 2011) were identified.
The medical records of six of these patients were in-
complete and they were excluded from the study.
The following clinical data were abstracted from the
medical records: clinical setting (inpatient and outpatient);age; diagnosis; sex; indications as to thoracenthesis (diag-
nostic or therapeutic, diagnostic, and therapeutic); chest
radiography findings pre-and post- thoracentesis; pneu-
mothorax; and tube thoracostomy rate.
Eleven patients in whom no prior chest X-ray or fol-
lowing thoracentesis were available or with pre-existing
hydropneumothorax at admission to our departments
were excluded from the study.
The final group of cases which was the object of this
study consisted of 445 evaluable patients.
The patients were divided into two groups: group A,
conventional thoracentesis traditional land mark method);
and group B, US-guided thoracentesis.
US-guided or conventional thoracentesis was performed
by one of five experienced physicians of the departments
(LC, PM, RB, MAP, GC) both for groups A and B.
The decision to perform US-guided or conventional
thoracentesis was made by the availability or otherwise
of US machines at bedside at the moment of thoracent-
esis. The two groups were not homogeneous since in
our departments thoracentesis is performed preferably
with US guidance; diagnostic thoracenteses were 5.19%
in group A and 11.29% in group B.
All the patients in this study had a pre- and post-
thoracentesis chest X-ray.
Once the location of the pleural fluid was identified by
physical examination or by US (Esaote, Genoa, Sonosite,
Milan, Italy equipped with two transducers between 3.5
to 7.5 MHZ), the area was cleaned with povidone-iodine
and local anesthesia and (1% lidocaine without epineph-
rine) was injected intradermally subcutaneously using a
22-gauge needle into the parietal pleura with or without
US guidance. A 14-gauge cannula catheter needle system
(ABBOCATH.T, HOSPIRA Inc., Philippines) was used
to enter the pleural space at the same point as the local
anesthesia, with or without US guidance.
Once the pleural space was entered, the needle was
withdrawn and fluid was removed through the catheter.
All patients included in the study signed informed con-
sent before undergoing the procedure. This study was
approved by the local ethical committee.
Statistical analysis
Categorical variables were summarized as counts and per-
centages, continuous variables using median and range.
Comparisons of group A versus group B, pneumo-
thorax versus no pneumothorax, outpatients versus in-
patient for various variables were performed using Yates
corrected chi square test. In all cases, two-tailed P values
of 0.05 or less were considered statistically significant.
All data were analyzed with OPENEPI statistical com-
puter software. When at least one expected value
(row total * column total/grand total) was <5, Fisher’s
exact test was used. Student’s t-test to calculate the
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viation was used.
Results
Clinical characteristics of the 445 patients who underwent
US-guided or unguided thoracentesis are reported in Table 1.
All 445 cases had malignant pleural effusion.
There were 252 male (56.63%) and 193 female (43.37%)
patients. The mean age of the group was 70.96 (±9.215)
years (range, 18-88 years), 156 (35.06%) were inpatients:
72 in group A and 84 in group B, and 289 (64.94%) outpa-
tients, 63 in group A and 226 in group B.
A total of 195 patients had lung cancer (43.82%), 175
breast cancer (39.33%), 35 gastrointestinal cancer (7.86%),
40 (8.99%) other cancers (mesotelioma, lymphoma, gynae-
cological cancer, and so on). US was used to guide thora-
centesis in 310 of 445 cases (69.66%), including 37 out of
42 (88.1%) diagnostic located thoracentesis, while in 135
(30.34%) cases thoracentesis was performed without US
guidance.
The volume of fluid removed was higher for thora-
centesis performed with US guidance compared with
the procedures done without US guidance: median;
1,100 mL (range, 70-2,300 mL) versus 750 mL (range,
40-1,700 mL) (Table 1). There were no significant corre-
lations between the drainage amount and pneumothorax
(P value = 0.447).
Fifteen of 445 patients (3.37%) who underwent thora-
centesis had pneumothorax; among them, three patients
(20%) required insertion of a chest tube for a symptom-
atic or enlarging pneumothorax (Table 2).Table 1 Clinical characteristics of 445 cancer patients with ma






Age (mean) (range) 70.9 (19-87)
Final diagnosis N (%)
Lung cancer 70 (51.86)
Breast cancer 56 (41.48)
Gastrointestinal cancer 4 (2.96)
Other 5 (3.70)
Diagnostic thoracentesis 7 (5.19)
Therapeutic thoracentesis 103 (76.30)
Diagnostic and therapeutic thoracentesis 25 (18.51)
Volume of pleural fluid removed (mL)
Median (range) 750 40-1,700In group A (conventional thoracentesis) 12 pneumothoraces
occurred (8.89%), while in group B (thoracentesis performed
with US guidance) only three (0.97%) pneumothoraces oc-
curred (P <0.0001) (Table 2).
All three chest tubes were inserted in patients with
pneumothorax secondary to thoracentesis performed
without US guidance. No significant correlations were
found between the occurrence of pneumothorax after
thoracentesis and type of cancer.
Discussion
Thoracentesis is a diagnostic and therapeutic procedure
that is routinely performed for evaluation of pleural effu-
sion and to relieve symptoms.
The most common reported thoracentesis complica-
tion is the puncture of the visceral pleura, which can
cause a pneumothorax [10].
US guidance allows the physician to determine a more
accurate needle insertion depth into the intercostal space
and thus reduces the incidence of pneumothorax [2,3,5].
It must be emphasized that most studies of US-guided
thoracentesis do not use real-time guidance for needle
insertion, but insert the needle immediately after identi-
fication, with US, of the appropriate site [4].
In our study, the needle was inserted under US real-
time guidance, allowing a procedure which was safer
and gave less discomfort to the patient. In fact, US guid-
ance also allows for dynamic needle visualization, enab-
ling precise needle placement.
Thoracentesis is typically thought to be a relatively
safe procedure with few complications; the incidence oflignant pleural effusion undergoing US-guided (group B)














Table 2 Number of pneumothorax and chest tube insertion following conventional thoracentesis and US-guided
thoracentesis
Pneumothorax and chest tube insertion in
cancer patients undergoing thoracentesis
Conventional thoracentesis Thoracentesis with US guidance P value
N % N % N %
All patients 445 100 135 30.34 310 69.66
Pneumothorax 15 3.37 12 8.89 3 0.97 0.00001
Chest tube insertion 3 20 3 2.22 0 0 0.054
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as 20% to 39% [5].
The National Confidential Enquiry into perioperative
deaths has reported one death resulting from a procedural-
induced pneumothorax [11].
It must be emphasized that less serious discomfort
(though unpleasant for the patient), clinicians’ time, hos-
pital stay, and economic costs are variables rates from
iatrogenic pnemothorax [12].
Several studies have demonstrated that US guidance
can reduce the rate of pnemothorax [5,7-9]. Grogan
et al. [5] found a significant reduction of the pneumo-
thorax rate when US was utilized for identification of
needle placement (0% versus approximately 29%).
Similar reductions in the rate of pneumothorax were
reported by other authors [7-9].
In addition the occurrence of pneumothorax requiring
tube thoracostomy is also significantly reduced with US
guidance as reported in the present study, and this is
considered even more clinically relevant [8,9].
Another very important benefit of US guidance is the
increased success in thoracentesis also after a clinically
failed directed thoracentesis: it has been demonstrated
that fluid can be successfully obtained in up to 88% of
patients after an unsuccessful by clinically guided thora-
centesis [9,13-16] and even more importantly in 58% of
clinically attempted ‘dry taps’ the needle insertion site
was found to be below the diaphragm [15].
US guidance increased the rate of accurate site selec-
tion by 26% and decreased the number of mean misses,
the number of potentially dangerous needle insertion
sites by 10% when compared to fluid localization by
physical examination and chest radiography [16].
In our study, we found a statistical significant reduction
in the pneumothorax rate after thoracentesis when US
guidance was utilized: three (0.97%) versus 12 (8.89%)
without US guidance (P <0.0001), and also a reduction in
tube thoracostomy: 0 (0%) versus three (100%).
It must be emphasized that our data concern cancer
patients. To our knowledge, this is the first report of this
setting of patients.
In view of the above, the advantages of US-guided
thoracentesis are demonstrated also in cancer patients;
and we recommend that the use of US for thoracentesisbe considered for all patients with cancer and pleural
effusion. Should patients undergoing thoracentesis be
referred to interventional radiologists for US-guided
procedure, or should it be a clinician (oncologist,
hematologist, internist, or a physician from another med-
ical specialty) that performs the US-guided procedure?
Thoracentesis by interventional radiologists under US
guidance include the necessity of moving the patient to
the radiology suite with the additional cost of the proced-
ure in the US suite [1]. Although interventional US guid-
ance is well-established in such specialties as radiology,
cardiology, and obstetrics and gynecology, it is becoming
more common across a range of specialties and proce-
dures [17].
In addition, it must be emphasized that the use of US
is not limited to radiologists [4]; the American Medical
Association policy favors US imaging technique diffusion
in medical practice [18]; the American College of Emer-
gency Physicians and the American College of Surgeons
support the use of US by members of their societies and
address ways to obtain and maintain competence as well
as ensuring quality control [19,20]. We agree with previ-
ous report [4] that US is an excellent teaching tool, and
in our departments we use it routinely to reinforce the
physical examination of residents and medical students.
In our departments oncologists, hematologists, and in-
ternists have performed US imaging procedures as well
as interventional US in clinical practice for the manage-
ment of patients (diagnosis, staging, restaging follow-up)
for almost 25 years [12,21-26]. So this procedure was
early applied to guide thoracentesis, performed by physi-
cians at the bedside without moving the patients to the
radiology suite.
David Kopman Feller 2007 [27] stated that US is an
easily learned technique that not only enhances the
physical examination but has also the distinct advantage
of being a portable tool that can provide real-time guid-
ance for thoracentesis and other interventional proce-
dures such as biopsy, abscess drainage, paracentesis, and
central venous catheter insertion. In addition, this pro-
cedure can be performed easily at the bedside as re-
ported in our study.
Gordon et al. [10] in their systematic review and meta-
analysis showed that the most important strategy to
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the use of US guidance, and they encourage institutions
to consider a policy of uniform use of US guidance for
thoracentesis, and more recently Patel et al. [17] showed
that US-guided thoracentesis is associated with lower
total hospital stay, lower costs, and lower incidence of
pneumothorax and hemorrhage. In addition, the Patient
Protection and Affordable Care Act of 2010 and the
Centers for Medicare and Medicaid Services Reporting
Hospital Quality Data for Annual Payment Update Pro-
gram Quality Measures FY 2012–2014 identify as major
goals for better healthcare delivery, safer medical care,
and avoidance of preventable complications, including
iatrogenic pneumothorax [28-30].
More recent literature highlights the safety and effi-
cacy of US-guided thoracentesis. These data indicate
that US guidance is associated with decreased risk of
pneumothorax. This complication results in a measur-
able increase in hospitalization costs and length of stay
[31,32].
Conclusions
The results of the present study, show that US-guided
thoracentesis in cancer patients is a safe, cheap, and ef-
fective technique in reducing both pneumothotax rate
and tube thoracostomy rate.
Based on these findings, on previous reports [1-10,17,31]
and on the availability of portable US machines, we
believe that the time has come to perform all thoracent-
eses in cancer patients under US guidance, thus impro-
ving safety and avoiding complications and patient
discomfort.
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